Select a Region North America

Insights

Insights From Our Experts

Articles

Develop Patient Support Programs Focused on Patients

We have to get intimate with patient populations and advocacy groups to build best-in-class patient support programs from the start.

Providing a Patient-Driven Experience

As the “patient-as-consumer” culture enables patients to consider all their varied care options, they increasingly want to be involved not only by participating in clinical trials, but also by accelerating product development and the availability of…

patient-quiz
Put Your Patient Services Program to the Test

How well do you really know your patients? Global Genes reports that therapy adherence in the rare disease space can vary from 58 to 65 percent, a troubling statistic for our industry, and most importantly, the…

biosimilar in new patients
New start versus switch patients for biosimilars?

Over the last several years, European market demand for biosimilars has accelerated with the entry of biosimilars for many reference biologics, including high-value molecules such as adalimumab, infliximab and etanercept. However, there have been reported variations…

Precision Medicine Meets Precision Patient Support

In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary…

Decoding EMA’s Blueprint on Real-World Evidence

The European Medicines Agency (EMA) has published a document that elaborates on the application of Real-World Data (RWD) in evaluating human medicines. This document succinctly outlines the utility of Real-World Evidence (RWE), which is derived from…

Predicting Telehealth Use through the Power of Machine Learning: Insights from EVERSANA to Be Shared at Upcoming PMSA Conference.

Telehealth has emerged as a vital channel for health services delivery in the post-COVID era. However, understanding patient telehealth use remains a complex challenge for healthcare providers. At EVERSANA, our experts are leveraging machine learning techniques…

Navigating Pharmaceutical Success: Harnessing Data Analytics and Predictive Modeling

In the fast-paced world of pharmaceuticals, where market forecasting and regulatory compliance are paramount, data-driven insights can make all the difference. Discover how EVERSANA’s Specialty Consulting team excels in crafting tailored predictive modeling solutions for pharmaceutical…

Sound Off on Interoperability – Leveraging Next-Gen Tech for Enhanced Electronic Benefit Verification and Prior Authorizations to Streamline Workflow

The theme of a recent panel at Access USA was “Technology: the Good, the Bad, and the Ugly.” While serving as an instrument for addressing challenges, technological progress can also introduce new complexities.  Watch the recording…

V&E New Leaders 2024 EVERSANA HEOR
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur

EVERSANA’s Value and Evidence (V&E) team grew their global Health Economics & Outcomes Research (HEOR) leadership footprint in early 2024 with the addition of Monique Martin, Pamela Vo and Deepika Thakur, showcasing EVERSANA’s growing global life…